SNT 0.00% 3.9¢ syntara limited

Ann: Pharmaxis Quarterly Shareholder Update and Investor Briefing, page-3

  1. 5,664 Posts.
    lightbulb Created with Sketch. 669
    Chiesi still making excuses in US

    There should always be solutions to overcome temporary roadblocks particularly for life saving drugs NOT EXCUSES and forecasting of revenue downgrades - kick them out

    why can’t they sell it to one of the big pharma? Probably too difficult to manufacture?

    excuses excuses


 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.000(0.00%)
Mkt cap ! $44.17M
Open High Low Value Volume
3.9¢ 4.0¢ 3.7¢ $66.77K 1.752M

Buyers (Bids)

No. Vol. Price($)
1 2713 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 209403 1
View Market Depth
Last trade - 14.38pm 24/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.